查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1855378

伴侶動物診斷市場按診斷測試類型、產品類型、動物類型、最終用戶和應用分類－2025-2032年全球預測

Companion Animal Diagnostics Market by Type Of Diagnostic Test, Product Type, Animal Type, End-User, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，伴侶動物診斷市場規模將達到 65.5 億美元，複合年成長率為 8.88%。

關鍵市場統計數據
基準年 2024 33.1億美元
預計年份：2025年 35.9億美元
預測年份 2032 65.5億美元
複合年成長率 (%) 8.88%

一篇關於不斷發展的伴侶動物診斷環境的簡明說明重點介紹了再形成醫療保健的技術、臨床和監管促進因素。

由於技術創新、臨床實踐的轉變以及飼主對更精準、更及時的獸醫服務的日益成長的期望，伴侶動物診斷領域正以前所未有的速度發生變化。檢測設計、影像技術和分子技術的進步使得疾病的早期發現、更個人化的治療方案以及治療效果的監測成為可能。隨著獸醫診所採用更先進的內部檢測能力，即時篩檢和實驗室級診斷之間的界線日益模糊，重塑診所和專科中心的工作流程模式和服務內容。

法律規範和專業指南同步發展，影響診斷工具和服務的驗證標準、品管預期以及資料管治實務。這種動態的監管環境促使製造商和服務供應商加強證據生成、聲明佐證和上市後監測活動。同時，從尋求快速臨床決策支援的臨床醫生到尋求透明度和連續性護理的飼主，相關人員的期望正在推動互操作系統、標準化報告格式和更清晰的療效指標的出現。

綜合來看，這些因素正在重新定義競爭優勢。那些能夠將強大的分析性能與臨床工作流程的無縫整合、卓越的客戶支援以及經臨床驗證的效用相結合的公司，更有可能獲得最持久的市場地位。本導言將重點放在這些變革性變化及其對診斷生態系中各參與者的影響。

對將徹底改變獸醫實踐中診斷技術、臨床工作流程和商業模式的重大變革進行清晰的描述

伴侶動物診斷產業的格局正受到多項變革性因素的重塑，這些因素共同作用，重新定義了該產業的整體價值提案。首先，分子診斷和次世代定序的成熟，拓展了診斷套件的範圍，使其超越了傳統的形態學和血清學檢測，從而能夠進行精準的病原體鑑定、遺傳風險分析和靶向腫瘤檢測。同時，即時檢測技術和小型化分析儀的出現，使得檢測分散化，許多診所能夠在現場進行血液學、化學和快速傳染病檢查，從而縮短診斷時間，並有助於即時進行臨床干預。

資訊學和數據整合也日益凸顯。雲端基礎平台、實驗室資訊系統和診斷中間件正在改善樣本追蹤、結果解讀和病患監測。這個數位化層面支援決策支援演算法，並促進遠距會診、遠端醫療追蹤以及新發病原體的群體監測。此外，標準化品管和認證計畫的日益普及也提高了醫療服務提供者對分析可靠性的基本期望。

試劑和耗材的訂閱式服務協議、捆綁式診斷包以及伴隨診斷的價值基本契約正逐漸成為供應商的戰略選擇。將臨床證據產生、工作流程整合和敏捷服務模式融入產品中的公司將更有利於吸引臨床醫生並建立長期的業務關係。

對2025年關稅調整將如何影響供應鏈韌性、區域籌資策略和臨床醫生採購行為進行實際分析

計劃於2025年實施的關稅調整和貿易政策變化，為伴侶動物診斷供應鏈中的製造商、經銷商商和終端用戶帶來了新的營運挑戰。某些市場對醫療設備和試劑徵收更高的進口關稅，擠壓了依賴全球採購的供應商的利潤空間，促使他們重新評估分銷策略、定價模式和供應商關係。擁有地理位置分散的生產基地和靈活的製造外包協議的製造商可以緩解近期成本壓力，並穩定向獸醫診所和實驗室的供應。

除了直接的成本影響外，關稅還在推動供應鏈的策略轉型。一些供應商正在加速零件生產和最終組裝的在地化進程，以降低跨境關稅和運輸中斷帶來的風險。這種在地化趨勢正在影響前置作業時間、庫存策略以及擴張和合作的資本投資決策。對於最終用戶而言，採購團隊正在重新審視總體擁有成本的計算方法，將關稅引起的價格波動、運費以及關稅相關的延誤納入考量。

同時，關稅驅動的市場動態正在影響臨床應用模式。當進口診斷平台的價格競爭力下降時，本地替代方案和模組化內部檢測開發可能會更受歡迎，尤其是在那些有能力檢驗新檢測方法的大型獸醫診所和研究中心。製造商與經銷商之間進行策略合作，提供捆綁服務、延長保固期和培訓，可以抵消預期成本上漲的影響，並在關稅相關的不確定性中維持臨床服務的連續性。

詳細的細分洞察揭示了診斷測試類型、產品類別、動物群體、最終用戶環境和臨床應用如何影響策略重點。

透過精細的細分視角，我們可以清楚地了解臨床需求、技術契合度和機會在多個診斷類別中的交集。診斷測試類型包括血液學測試（例如凝血試驗和全血細胞計數）、組織病理學程序（包括切片檢查和細胞學工作流程）、影像學（包括超音波和X光）、分子平台（包括DNA序列測定和基於PCR的檢測）以及血清學方法（包括凝集試驗和ELISA檢測）。每種測試類型都有不同的分析要求、檢體處理通訊協定和訓練需求，這些都會影響獸醫診所和參考實驗室的採購決策。

產品類型分為耗材和儀器/分析儀，其中耗材定義為試劑和檢測套組，儀器定義為臨床化學分析儀、血液分析儀、免疫診斷分析儀、分子診斷儀器等類別。這種分類突顯了試劑的經常性成本與分析儀的資本支出在採購節奏上的差異，進而影響供應商的收入模式與銷售策略。

動物物種涵蓋鳥類、貓、狗、豚鼠和馬，這種多樣性要求檢測方法的驗證必須考慮物種特異性參考區間、樣本基質以及臨床解讀框架。最終使用者細分包括內部實驗室、研究實驗室和獸醫醫院/診所，其中內部實驗室又可進一步細分為動物收容所和寵物飼主，反映了不同的資源規模和技術能力。應用細分包括內分泌檢測、基因檢測、感染疾病診斷、營養分析、腫瘤學、治療藥物監測和毒理學檢測等領域。認知到這些相互交織的細分維度，有助於相關人員優先制定針對不同最終用戶群體的產品藍圖、檢驗測試和商業性策略。

策略性區域洞察，闡釋美洲、歐洲、中東和非洲以及亞太市場在採用率、監管和商業模式方面的差異

區域動態對技術採納、監管路徑和商業實施策略有顯著影響。在美洲，高度集中的專業獸醫診所和先進的參考實驗室，以及完善的分銷網路和成熟的私人診所生態系統，正推動著高通量分子診斷和整合診所管理工作流程的快速普及。相較之下，歐洲、中東和非洲地區（EMEA）的情況則較為複雜，監管協調工作與市場分散並存。在西歐，成熟的獸醫診所推動了對經過驗證和認證的解決方案的需求，而新興市場則優先考慮能夠應對該地區疾病負擔的、經濟高效且適應性強的診斷方案。

在亞太地區，快速的都市化、寵物飼養量的成長以及獸醫教育基礎設施的不斷完善，正推動著對就地檢驗和先進化驗服務的需求。在地化生產和區域合作在亞太地區日益重要，有助於加速市場進入並應對價格敏感度問題。在所有地區，報銷模式、診所整合趨勢以及專科培訓計畫的差異，都在影響診斷技術普及的速度和模式。為了實現持續普及，供應商必須根據這些區域差異調整其打入市場策略，在標準化的全球產品平台與特定區域的監管措施、分銷框架和服務模式之間取得平衡。

提供切實可行的公司層面洞察，重點在於競爭差異化策略、夥伴關係途徑和創新重點，以實現永續的市場滲透。

隨著現有企業、專業設備製造商、試劑供應商和創新分子診斷公司尋求差異化的價值提案，伴侶動物診斷領域的競爭格局正在不斷演變。成功越來越依賴整合式解決方案，即可靠的儀器、高效的耗材、簡化的工作流程和強大的售後服務。那些投資於臨床證據產生、第三方檢驗和跨物種參考數據的公司，正在贏得獸醫臨床醫生和實驗室主任的信任，從而幫助他們維持長期的採購合作關係。

聯盟和策略夥伴關係正逐漸成為加速市場滲透的有效途徑。將診斷專長與數位健康平台、遠端醫療提供者或診所管理系統結合的聯盟，能夠打造極具吸引力的捆綁式解決方案，有效解決臨床醫生工作流程中的痛點，並改善患者預後追蹤。此外，投資於培訓、遠距離診斷支援和技術服務網路的機構，能夠降低使用者接受新方案的門檻，並提高客戶維繫。

試劑化學、微射流和可攜式設備的創新正在開闢新的競爭領域，速度、易用性和檢測的穩定性決定臨床醫生的偏好。那些圍繞終端使用者實際需求（例如有限的實驗台空間、可變的樣本量以及對快速、可操作結果的需求）開發產品的公司，更有可能在市場上取得成功。最後，透明的上市後監測和對監管變化的快速反應將有助於增強信任，並降低新技術應用的門檻。

為行業領導者提供切實可行的、優先排序的建議，以協調產品、證據、定價和分銷策略，從而推動臨床應用和成長。

透過將產品、證據和市場策略與不斷變化的臨床需求相匹配，行業領導者可以果斷行動，將市場動態轉化為競爭優勢。首先，他們優先考慮模組化產品架構，使產品功能能夠從基礎血液學和化學檢測擴展到更高級的分子和血清學檢測，而無需昂貴的資本投入。這種方法降低了產品推廣的門檻，並透過升級路徑支持長期的客戶關係。同時，他們投資於可靠的臨床檢驗研究和跨物種參考數據，以證明產品在最常見的伴侶動物群體中的分析性能和臨床效用。

在商業性，我們採用靈活的合約模式，結合資本設備租賃、試劑訂閱計劃和配套服務，以滿足從小型診所到大型轉診中心等不同終端用戶的財務能力。當關稅影響或物流限制可能削弱競爭力時，我們透過發展本地製造和組裝夥伴關係關係來加強區域分銷。為了最大限度地減少實施摩擦並增強臨床醫生的信心，我們還提供有針對性的培訓計劃、遠端技術支援和品質保證資源，以完善產品供應。

最後，它們整合了數位化功能，從而增強了結果解讀、數據共用和患者長期追蹤。它們可以連接到診所管理系統，並提供可互通的報告格式，從而支援遠端醫療工作流程。隨著伴侶動物診斷領域的不斷成熟，專注於模組化、證據生成、客戶支援和數位化整合將使行業領導者能夠獲得長期價值。

透明的調查方法，闡明了支撐策略洞見的資訊來源、專家參與、分析框架和限制。

本分析的研究結合了對同行評審的獸醫臨床文獻、監管指導文件和產品技術規範的結構化審查，以及對實驗室主任、獸醫臨床醫生、經銷商和產品經理的訪談。資料綜合強調跨多個資訊來源進行三角驗證，以檢驗技術能力、工作流程影響和區域應用模式。定性專家意見有助於解讀臨床效用和操作可行性，而二手資訊則提供了監管發展和供應鏈動態的背景資訊。

分析方法包括診斷平台的功能比較映射、跨物種檢測驗證方法的評估以及情境分析，以評估關稅主導的供應鏈應對措施。研究強調了調查結果的可重複性和假設的透明度，並且在預測反映了專家對採用可能性或營運影響的意見時，這些判斷得到了多位從業人員訪談的支持。這項研究應被視為策略指南，並需輔以持續的市場監測和本地營運環境中的檢驗。

調查方法確保所提出的見解是基於實踐者的實際情況、檢驗的技術特性和實際的商業性考慮，使決策者能夠將研究結果應用於他們的產品開發、採購和臨床整合策略。

簡明扼要的結論，整合了伴侶動物診斷策略定位的技術、監管和商業性必要性。

總之，伴侶動物診斷正處於一個戰略曲折點，技術進步、照護模式轉變、法規演變和經濟壓力交織在一起，重塑價值創造的格局。分子創新、照護現場能力的提升以及數位化工作流程的整合，在提高診斷準確性的同時，也正在改變傳統的實驗室服務關係。同時，政策措施和關稅調整迫使供應商和經銷商重新評估籌資策略，並增強本地供應鏈的韌性。

對於整個生態系統的相關人員而言，未來的發展路徑包括：將產品創新與臨床效用檢驗相結合；建構反映終端用戶經濟實際情況的商業模式；以及投資於能夠減少推廣阻力的服務框架。本地差異至關重要。針對當地法規環境、分銷基礎設施和臨床實踐模式的精準市場策略，優於一刀切的通用策略。最終，那些能夠平衡技術卓越性與務實商業化（並以循證醫學、培訓和快速響應的支持為支撐）的機構，將引領下一階段的推廣應用，並創造可衡量的臨床和商業價值。

該結論綜合了關鍵見解，並強調了在快速發展的診斷環境中，制定積極主動的策略以抓住機會和降低營運風險的必要性。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 寵物飼養量的增加和寵物擬人化趨勢推動了對診斷的需求。
  • 將照護現場免疫檢測設備整合到獸醫診所進行快速診斷
  • 獸醫診所擴大使用分子PCR檢測進行疾病早期診斷。
  • 遠端醫療診斷平台在遠距伴侶動物照護方面的進展
  • 人工智慧主導的影像分析技術的出現提高了小動物診斷的準確性
  • 人們對照護現場超音波進行伴侶動物全面評估的興趣日益濃厚
  • 擴展多重生物標記檢測組合，用於寵物慢性疾病的早期檢測
  • 擴大獸醫基礎設施以支持廣泛的診斷
  • 政府的積極措施和寵物保險的普及正在推動市場擴張。
  • 動物用藥品研發與策略合作推動創新

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 伴侶動物診斷市場（依診斷檢驗類型分類）

  • 血液學
    • 血液凝固檢查
    • 全血細胞計數（CBC）
  • 組織病理學
    • 切片檢查
    • 細胞學
  • 影像診斷
    • 超音波
    • X光
  • 分子診斷
    • DNA定序
    • PCR方法
  • 血清學
    • 團聚檢測法
    • 酵素連結免疫吸附試驗

9. 伴侶動物診斷市場（依產品類型分類）

  • 消耗品
    • 試劑
    • 檢測套組
  • 儀器/分析儀
    • 臨床化學分析儀
    • 血液分析儀
    • 免疫診斷分析儀
    • 分子診斷分析儀

第10章 按動物類型分類的伴侶動物診斷市場

  • 鳥類
  • 貓
  • 狗
  • 天竺鼠
  • 馬

第11章 伴侶動物診斷市場（依最終用戶分類）

  • 內部測試設施
    • 動物收容所
    • 寵物飼主
  • 研究所
  • 獸醫醫院和診所

第12章 伴侶動物診斷市場（依應用領域分類）

  • 內分泌檢測
  • 基因檢測
  • 感染疾病診斷
  • 營養分析
  • 腫瘤學
  • 治療藥物監測
  • 毒理學檢測

13. 伴侶動物診斷市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 伴侶動物診斷市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 各國伴侶動物診斷市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Bio-Rad Laboratories, Inc.
    • Thermo Fisher Scientific Inc.
    • Agrolabo SpA
    • Biogal Galed Labs
    • BioMerieux SA
    • BioNote, Inc.
    • Demeditec Diagnostics GmbH
    • Eurofins Technologies
    • Fassisi GmbH
    • FUJIFILM Holdings Corporation
    • IDEXX Laboratories, Inc.
    • IDvet
    • Mars, Incorporated
    • Neogen Corporation
    • Nisseiken Co., Ltd
    • Qiagen NV
    • Randox Laboratories, Ltd.
    • Shenzhen Bioeasy Biotechnology Co., Ltd.
    • Shenzhen Mindray Animal Medical Technology Co., Ltd.
    • SKYER, Inc.
    • Skyla Corporation
    • Vimian Group AB
    • Virbac SA
    • Zoetis Inc.
Product Code: MRR-AD517FAA89C5

The Companion Animal Diagnostics Market is projected to grow by USD 6.55 billion at a CAGR of 8.88% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 3.31 billion
Estimated Year [2025] USD 3.59 billion
Forecast Year [2032] USD 6.55 billion
CAGR (%) 8.88%

A concise orientation to the evolving companion animal diagnostics environment highlighting technological, clinical, and regulatory drivers reshaping care

The companion animal diagnostics landscape is undergoing a period of accelerated transformation driven by converging technological innovation, shifting clinical practices, and heightened owner expectations for more precise and timely veterinary care. Advances in assay design, imaging modalities, and molecular techniques are enabling earlier detection of disease, more personalized treatment pathways, and improved monitoring of therapeutic outcomes. As veterinary practices adopt more sophisticated in-house testing capabilities, the boundary between point-of-care screening and laboratory-grade diagnostics continues to blur, reshaping workflow models and service offerings across clinics and specialty centers.

Regulatory frameworks and professional guidelines are evolving in parallel, influencing validation standards, quality control expectations, and data governance practices for diagnostic tools and services. This dynamic regulatory context is prompting manufacturers and service providers to strengthen their evidence generation, claim substantiation, and post-market surveillance activities. Meanwhile, stakeholder expectations-from clinicians seeking rapid clinical decision support to pet owners demanding transparency and continuity of care-are incentivizing interoperable systems, standardized reporting formats, and clearer outcome metrics.

Taken together, these forces are redefining competitive differentiation. Companies that combine robust analytical performance with seamless integration into clinical workflows, strong customer support, and demonstrable clinical utility will secure the most durable positions in the market. The introduction sets the stage for a focused examination of these transformative shifts and their implications for players across the diagnostics ecosystem.

Clear articulation of the major transformative shifts altering diagnostic technologies, clinical workflows, and commercial models across veterinary practice

The landscape for companion animal diagnostics is being reshaped by several transformative shifts that are converging to redefine value propositions across the industry. First, the maturation of molecular diagnostics and next-generation sequencing has expanded the diagnostic toolkit beyond traditional morphology and serology, enabling precise pathogen identification, genetic risk profiling, and targeted oncology testing. Concurrently, point-of-care technologies and compact analyzers are decentralizing testing, allowing many practices to perform hematology, chemistry, and rapid infectious disease assays on-site, which shortens time-to-diagnosis and facilitates immediate clinical interventions.

Informatics and data integration are also rising to the fore. Cloud-based platforms, laboratory information systems, and diagnostic middleware are improving sample tracking, result interpretation, and longitudinal patient monitoring. This digital layer supports decision support algorithms and facilitates remote consultations, telemedicine follow-ups, and population-level surveillance of emerging pathogens. Additionally, growing adoption of standardized quality controls and accreditation programs is raising baseline expectations for analytical robustness across providers, which in turn influences procurement decisions and client trust.

Finally, economic and service delivery models are evolving: subscription-based service arrangements for reagents and consumables, bundled diagnostic packages, and value-based contracting for companion diagnostics are emerging as strategic approaches for suppliers. Organizations that embed clinical evidence generation, workflow integration, and responsive service models into their offerings will be better positioned to capture clinician adoption and long-term account relationships.

Practical analysis of how 2025 tariff adjustments are influencing supply chain resilience, regional sourcing strategies, and clinician procurement behavior

Tariff adjustments and trade policy changes slated for 2025 are creating a new set of operational considerations for manufacturers, distributors, and end-users in the companion animal diagnostics supply chain. Increased import duty levels on medical devices and reagents in select markets have compressed margins for vendors that rely on global sourcing, prompting a re-evaluation of distribution strategies, pricing models, and supplier relationships. Manufacturers with geographically diversified production footprints or flexible contract manufacturing arrangements are better able to mitigate near-term cost pressures and stabilize supply commitments to veterinary clinics and laboratories.

Beyond immediate cost implications, tariffs are catalyzing strategic shifts in supply chain architecture. Some suppliers are accelerating localization of component production and final assembly to reduce exposure to cross-border duties and shipping disruptions. This localization trend is influencing lead times, inventory policies, and capital investment decisions for facility expansions or partnerships. For end-users, procurement teams are revisiting total-cost-of-ownership calculations that incorporate tariff-driven price volatility, freight, and customs-related delays.

At the same time, tariff-driven market dynamics are influencing clinical adoption patterns. Where imported diagnostic platforms become less price-competitive, regional alternatives and modular in-house assay development may gain traction, especially in larger veterinary hospitals and research centers with capacity to validate new assays. Strategic collaboration between manufacturers and distributors to bundle services, offer extended warranties, and provide training can offset perceived cost increases and maintain continuity of clinical services amidst tariff-related uncertainty.

In-depth segmentation insights revealing how diagnostic test types, product classes, animal cohorts, end-user settings, and clinical applications shape strategic priorities

A granular segmentation lens clarifies where clinical need, technology fit, and commercial opportunity intersect across multiple diagnostic categories. The Type Of Diagnostic Test dimension includes hematology tests such as blood clotting assays and complete blood count panels, histopathology procedures encompassing both biopsy and cytology workflows, imaging modalities that cover ultrasound and X-ray diagnostics, molecular platforms spanning DNA sequencing and PCR-based assays, and serology approaches including agglutination assays and ELISA tests. Each test type carries distinct analytical requirements, specimen handling protocols, and training needs, which influence purchasing decisions across veterinary practices and reference laboratories.

Product Type segmentation differentiates consumables from instruments and analyzers, with consumables further characterized by reagents and test kits and instruments defined by categories such as clinical chemistry analyzers, hematology analyzers, immunodiagnostic analyzers, and molecular diagnostic instruments. This split underscores the divergent procurement rhythms between recurring reagent spend and capital expenditures for analyzers, shaping revenue models and sales strategies for suppliers.

Animal Type spans birds, cats, dogs, guinea pigs, and horses, and this diversity necessitates assay validation across species-specific reference ranges, sample matrix considerations, and clinical interpretation frameworks. End-User segmentation covers in-house testing facilities, research laboratories, and veterinary hospitals and clinics, with in-house testing facilities further segmented into animal shelters and pet owners, reflecting varying resource envelopes and technical capabilities. Application-focused segmentation includes areas such as endocrinology testing, genetic testing, infectious disease diagnostics, nutritional analysis, oncology, therapeutic drug monitoring, and toxicology testing; each application drives unique feature sets, regulatory needs, and evidence demands. Recognizing these intersecting segmentation vectors helps stakeholders prioritize product roadmaps, validation studies, and tailored commercial approaches for distinct end-user cohorts.

Strategic regional insights explaining how Americas, Europe Middle East & Africa, and Asia-Pacific markets diverge in adoption, regulation, and commercial models

Regional dynamics exert a powerful influence on technology adoption, regulatory pathways, and commercial execution strategies. In the Americas, a concentration of specialty veterinary practices and advanced reference laboratories favors rapid uptake of high-throughput molecular diagnostics and integrated practice-management workflows, supported by established distribution networks and a mature private practice ecosystem. In contrast, Europe, Middle East & Africa presents a heterogeneous landscape where regulatory harmonization efforts coexist with market fragmentation; established veterinary centers in Western Europe drive demand for validated, accredited solutions while emerging markets prioritize cost-effective, adaptable diagnostic options that address regional disease burdens.

In the Asia-Pacific region, rapid urbanization, growing pet ownership, and expanding veterinary education infrastructure are catalyzing demand for both point-of-care testing and advanced laboratory services. Local manufacturing and regional partnerships are increasingly important in Asia-Pacific, enabling faster market entry and responsiveness to price sensitivity. Across all regions, differences in reimbursement models, clinic consolidation trends, and professional training programs shape the pace and pattern of diagnostic uptake. Vendors must tailor their market entry strategies to account for these regional nuances, balancing standardized global product platforms with region-specific regulatory compliance, distribution frameworks, and service models to achieve sustainable adoption.

Actionable company-level insights highlighting competitive differentiation strategies, partnership pathways, and innovation priorities for sustained market relevance

Competitive dynamics within the companion animal diagnostics space are evolving as incumbent manufacturers, specialized instrument makers, reagent suppliers, and innovative molecular diagnostics firms seek differentiated value propositions. Success increasingly depends on integrated offerings that couple reliable instruments with validated consumables, streamlined workflows, and strong after-sales support. Companies that invest in clinical evidence generation, third-party validations, and cross-species reference data establish credibility with veterinary clinicians and laboratory directors, which helps sustain long-term procurement relationships.

Collaboration and strategic partnerships are emerging as effective pathways to accelerate market penetration. Alliances that combine diagnostic expertise with digital health platforms, telemedicine providers, or practice-management systems create compelling bundled solutions that address clinician workflow pain points and improve patient outcome tracking. Additionally, organizations that invest in training, remote diagnostics support, and technical service networks reduce adoption friction and enhance customer retention.

Innovation in reagent chemistry, microfluidics, and portable instrumentation is opening new competitive fronts where speed, ease of use, and assay robustness determine clinician preference. Firms that align product development with end-user realities-such as limited bench space, variable sample volumes, and the need for rapid actionable results-will command stronger market relevance. Finally, transparent post-market surveillance and responsiveness to regulatory developments reinforce trust and reduce adoption barriers for newer technologies.

Practical and prioritized recommendations for industry leaders to align product, evidence, pricing, and distribution strategies for clinical adoption and growth

Industry leaders can act decisively to convert market dynamics into competitive advantage by aligning product, evidence, and go-to-market strategies with evolving clinical needs. First, prioritize modular product architectures that allow clinics to scale capabilities from basic hematology and chemistry to more advanced molecular and serology testing without prohibitive capital outlays. This approach reduces adoption barriers and supports long-term customer relationships through upgrade pathways. In parallel, invest in robust clinical validation studies and cross-species reference data to demonstrate analytical performance and clinical utility across the most common companion animal cohorts.

Commercially, adopt flexible contracting models that combine capital equipment leasing, reagent subscription programs, and bundled service offerings to match the financial capacities of diverse end-users, from small clinics to large referral centers. Strengthen regional distribution by cultivating local manufacturing or assembly partnerships where tariff exposure or logistical constraints could undermine competitiveness. Complement product availability with targeted training programs, remote technical support, and quality assurance resources to minimize implementation friction and maximize clinician confidence.

Finally, integrate digital capabilities that enhance result interpretation, data sharing, and longitudinal patient tracking. Provide interoperable reporting formats that plug into practice-management systems and enable telemedicine workflows. By focusing on modularity, evidence generation, customer support, and digital integration, industry leaders will be positioned to capture long-term value as the companion animal diagnostics environment continues to mature.

Transparent research methodology explaining sources, expert engagement, analytical frameworks, and limitations to underpin the strategic findings

The research underpinning this analysis combined a structured review of peer-reviewed veterinary clinical literature, regulatory guidance documents, product technical specifications, and primary interviews with laboratory directors, veterinary clinicians, distributors, and product managers. Data synthesis emphasized triangulation across multiple sources to validate technology capabilities, workflow impacts, and regional adoption patterns. Qualitative inputs from subject-matter experts informed interpretation of clinical utility and operational feasibility, while secondary sources provided context on regulatory trajectories and supply chain dynamics.

Analytical methods included comparative feature mapping of diagnostic platforms, evaluation of assay validation approaches across species, and scenario analysis to assess tariff-driven supply chain responses. Emphasis was placed on reproducibility of findings and transparency of assumptions; where expert opinion informed projections about adoption likelihood or operational impacts, those judgements were corroborated with multiple practitioner interviews. Limitations include evolving regulatory actions and fast-moving technological developments that may shift dynamics after publication; accordingly, readers are encouraged to consider this research as a strategic compass that should be complemented with ongoing market monitoring and targeted validation in local practice settings.

The methodological approach ensures that the insights presented are grounded in practitioner realities, validated technical characteristics, and pragmatic commercial considerations, enabling decision-makers to apply findings to product development, procurement, and clinical integration strategies.

Concise conclusion synthesizing technological, regulatory, and commercial imperatives for strategic positioning in companion animal diagnostics

In conclusion, companion animal diagnostics stands at a strategic inflection point where technological advances, shifting care models, regulatory evolution, and economic pressures intersect to reshape value creation. The combination of molecular innovations, improved point-of-care capabilities, and integrated digital workflows is enhancing diagnostic precision while altering traditional laboratory-service relationships. Simultaneously, policy measures and tariff adjustments are prompting suppliers and distributors to reassess sourcing strategies and to strengthen regional supply resilience.

For stakeholders across the ecosystem, the path forward involves aligning product innovation with validated clinical utility, structuring commercial models that reflect end-user financial realities, and investing in service frameworks that reduce adoption friction. Regional nuance matters: targeted market approaches that consider local regulatory environments, distribution infrastructures, and clinical practice patterns will outperform one-size-fits-all strategies. Ultimately, organizations that balance technical excellence with pragmatic commercialization-backed by evidence, training, and responsive support-will lead the next phase of adoption and deliver measurable clinical and business value.

This conclusion synthesizes the principal insights and underscores the imperative for proactive strategy development to capture opportunity and mitigate operational risk in a rapidly evolving diagnostics environment.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising pet ownership and humanization of pets fueling daignostic demand
  • 5.2. Integration of point-of-care immunoassay devices in veterinary clinics for rapid diagnosis
  • 5.3. Rising adoption of molecular PCR testing in veterinary practices for early disease detection
  • 5.4. Advancements in telehealth-enabled diagnostic platforms for remote companion animal care
  • 5.5. Emergence of AI-driven imaging analytics to improve accuracy of small animal diagnostics
  • 5.6. Growing focus on point-of-care ultrasound adoption for comprehensive companion animal assessment
  • 5.7. Expansion of multiplex biomarker panels for early detection of chronic diseases in pets
  • 5.8. Expansion of veterinary infrastructure supporting diagnostic uptake
  • 5.9. Favorable government initiatives and pet insurance penetration boosting market expansion
  • 5.10. Rise in veterinary R&D and strategic collaborations driving innovation

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Companion Animal Diagnostics Market, by Type Of Diagnostic Test

  • 8.1. Hematology
    • 8.1.1. Blood Clotting Test
    • 8.1.2. Complete Blood Count (CBC)
  • 8.2. Histopathology
    • 8.2.1. Biopsy
    • 8.2.2. Cytology
  • 8.3. Imaging
    • 8.3.1. Ultrasound
    • 8.3.2. X-Rays
  • 8.4. Molecular Diagnostics
    • 8.4.1. DNA Sequencing
    • 8.4.2. PCR
  • 8.5. Serology
    • 8.5.1. Agglutination Assay
    • 8.5.2. Elisa Test

9. Companion Animal Diagnostics Market, by Product Type

  • 9.1. Consumables
    • 9.1.1. Reagents
    • 9.1.2. Test kits
  • 9.2. Instruments/Analyzers
    • 9.2.1. Clinical chemistry analyzers
    • 9.2.2. Hematology analyzers
    • 9.2.3. Immunodiagnostic analyzers
    • 9.2.4. Molecular diagnostic analyzers

10. Companion Animal Diagnostics Market, by Animal Type

  • 10.1. Birds
  • 10.2. Cats
  • 10.3. Dogs
  • 10.4. Guinea pigs
  • 10.5. Horses

11. Companion Animal Diagnostics Market, by End-User

  • 11.1. In-House Testing Facilities
    • 11.1.1. Animal Shelters
    • 11.1.2. Pet Owners
  • 11.2. Research Laboratories
  • 11.3. Veterinary Hospitals & Clinics

12. Companion Animal Diagnostics Market, by Application

  • 12.1. Endocrinology Testing
  • 12.2. Genetic Testing
  • 12.3. Infectious Disease Diagnostics
  • 12.4. Nutritional Analysis
  • 12.5. Oncology
  • 12.6. Therapeutic Drug Monitoring
  • 12.7. Toxicology Testing

13. Companion Animal Diagnostics Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Companion Animal Diagnostics Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Companion Animal Diagnostics Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Bio-Rad Laboratories, Inc.
    • 16.3.2. Thermo Fisher Scientific Inc.
    • 16.3.3. Agrolabo S.p.A.
    • 16.3.4. Biogal Galed Labs
    • 16.3.5. BioMerieux S.A.
    • 16.3.6. BioNote, Inc.
    • 16.3.7. Demeditec Diagnostics GmbH
    • 16.3.8. Eurofins Technologies
    • 16.3.9. Fassisi GmbH
    • 16.3.10. FUJIFILM Holdings Corporation
    • 16.3.11. IDEXX Laboratories, Inc.
    • 16.3.12. IDvet
    • 16.3.13. Mars, Incorporated
    • 16.3.14. Neogen Corporation
    • 16.3.15. Nisseiken Co., Ltd
    • 16.3.16. Qiagen N.V.
    • 16.3.17. Randox Laboratories, Ltd.
    • 16.3.18. Shenzhen Bioeasy Biotechnology Co., Ltd.
    • 16.3.19. Shenzhen Mindray Animal Medical Technology Co., Ltd.
    • 16.3.20. SKYER, Inc.
    • 16.3.21. Skyla Corporation
    • 16.3.22. Vimian Group AB
    • 16.3.23. Virbac S.A.
    • 16.3.24. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TYPE OF DIAGNOSTIC TEST, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TYPE OF DIAGNOSTIC TEST, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. COMPANION ANIMAL DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. COMPANION ANIMAL DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. COMPANION ANIMAL DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TYPE OF DIAGNOSTIC TEST, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TYPE OF DIAGNOSTIC TEST, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BLOOD CLOTTING TEST, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BLOOD CLOTTING TEST, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BLOOD CLOTTING TEST, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BLOOD CLOTTING TEST, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BLOOD CLOTTING TEST, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BLOOD CLOTTING TEST, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COMPLETE BLOOD COUNT (CBC), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COMPLETE BLOOD COUNT (CBC), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COMPLETE BLOOD COUNT (CBC), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COMPLETE BLOOD COUNT (CBC), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COMPLETE BLOOD COUNT (CBC), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COMPLETE BLOOD COUNT (CBC), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BIOPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BIOPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BIOPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BIOPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BIOPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BIOPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CYTOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CYTOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CYTOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CYTOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CYTOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CYTOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ULTRASOUND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ULTRASOUND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY X-RAYS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY X-RAYS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY X-RAYS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY X-RAYS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY X-RAYS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY X-RAYS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY AGGLUTINATION ASSAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY AGGLUTINATION ASSAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY AGGLUTINATION ASSAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY AGGLUTINATION ASSAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY AGGLUTINATION ASSAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY AGGLUTINATION ASSAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ELISA TEST, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ELISA TEST, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ELISA TEST, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ELISA TEST, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ELISA TEST, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ELISA TEST, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY ANALYZERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY ANALYZERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY ANALYZERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY ANALYZERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY ANALYZERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY ANALYZERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY ANALYZERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY ANALYZERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY ANALYZERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY ANALYZERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMMUNODIAGNOSTIC ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMMUNODIAGNOSTIC ANALYZERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMMUNODIAGNOSTIC ANALYZERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMMUNODIAGNOSTIC ANALYZERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMMUNODIAGNOSTIC ANALYZERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMMUNODIAGNOSTIC ANALYZERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC ANALYZERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC ANALYZERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC ANALYZERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC ANALYZERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC ANALYZERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BIRDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BIRDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BIRDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BIRDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BIRDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BIRDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CATS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CATS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CATS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CATS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CATS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CATS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY DOGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY DOGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY DOGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY DOGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY DOGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY DOGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GUINEA PIGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GUINEA PIGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GUINEA PIGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GUINEA PIGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GUINEA PIGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GUINEA PIGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HORSES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HORSES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HORSES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HORSES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HORSES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HORSES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL SHELTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL SHELTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL SHELTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL SHELTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL SHELTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL SHELTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PET OWNERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PET OWNERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PET OWNERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PET OWNERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PET OWNERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PET OWNERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ENDOCRINOLOGY TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ENDOCRINOLOGY TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ENDOCRINOLOGY TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ENDOCRINOLOGY TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ENDOCRINOLOGY TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ENDOCRINOLOGY TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY NUTRITIONAL ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY NUTRITIONAL ANALYSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY NUTRITIONAL ANALYSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY NUTRITIONAL ANALYSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY NUTRITIONAL ANALYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY NUTRITIONAL ANALYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TOXICOLOGY TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TOXICOLOGY TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TOXICOLOGY TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TOXICOLOGY TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TOXICOLOGY TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TOXICOLOGY TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 273. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 274. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 275. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TYPE OF DIAGNOSTIC TEST, 2018-2024 (USD MILLION)
  • TABLE 276. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TYPE OF DIAGNOSTIC TEST, 2025-2032 (USD MILLION)
  • TABLE 277. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2024 (USD MILLION)
  • TABLE 278. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2025-2032 (USD MILLION)
  • TABLE 279. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2018-2024 (USD MILLION)
  • TABLE 280. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2025-2032 (USD MILLION)
  • TABLE 281. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
  • TABLE 282. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2032 (USD MILLION)
  • TABLE 283. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 284. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 285. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, 2018-2024 (USD MILLION)
  • TABLE 286. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, 2025-2032 (USD MILLION)
  • TABLE 287. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 288. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 289. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 290. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 291. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2024 (USD MILLION)
  • TABLE 292. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2